On the public citation graph
A Randomized, Double-Blind, Placebo-Controlled Phase II Trial Investigating the Safety and Immunogenicity of Modified Vaccinia Ankara Smallpox Vaccine (MVA-BN®) in 56-80-Year-Old Subjects
0 signed · 115 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1001/jama.1970.03170160031005openalex-snapshot
Deaths Attributable to Smallpox Vaccination, 1959 to 1966, and 1968
inferredcites →https://doi.org/10.1001/jama.294.21.2734openalex-snapshot
Adverse Events Associated With Smallpox Vaccination in the United States, January-October 2003
inferredcites →https://doi.org/10.1007/bf01641272openalex-snapshot
Abstammung, Eigenschaften und Verwendung des attenuierten Vaccinia-Stammes MVA
inferredcites →https://doi.org/10.1016/j.amjmed.2008.08.019openalex-snapshot
Immunity from Smallpox Vaccine Persists for Decades: A Longitudinal Study
inferredcites →https://doi.org/10.1016/j.vaccine.2005.11.022openalex-snapshot
Safety and immunogenicity of IMVAMUNE, a promising candidate as a third generation smallpox vaccine
inferredcites →https://doi.org/10.1016/j.vaccine.2007.10.017openalex-snapshot
Clinical and immunologic responses to multiple doses of IMVAMUNE® (Modified Vaccinia Ankara) followed by Dryvax® challenge
inferredcites →https://doi.org/10.1016/j.vaccine.2009.05.095openalex-snapshot
Modified vaccinia Ankara strains with identical coding sequences actually represent complex mixtures of viruses that determine the biological properties of each strain
inferredcites →https://doi.org/10.1016/j.vaccine.2009.06.105openalex-snapshot
Evaluation of the efficacy of modified vaccinia Ankara (MVA)/IMVAMUNE® against aerosolized rabbitpox virus in a rabbit model
inferredcites →https://doi.org/10.1016/j.vaccine.2009.11.030openalex-snapshot
A randomized, double-blind, dose-finding Phase II study to evaluate immunogenicity and safety of the third generation smallpox vaccine candidate IMVAMUNE®
inferredcites →https://doi.org/10.1016/j.vaccine.2013.04.050openalex-snapshot
Safety and immunogenicity of IMVAMUNE® smallpox vaccine using different strategies for a post event scenario
inferredcites →https://doi.org/10.1016/j.vaccine.2014.02.043openalex-snapshot
Phase II randomized, double-blinded comparison of a single high dose (5×108 TCID50) of modified vaccinia Ankara compared to a standard dose (1×108 TCID50) in healthy vaccinia-naïve individuals
inferredcites →https://doi.org/10.1016/j.vaccine.2014.08.022openalex-snapshot
Safety and immunogenicity of modified vaccinia Ankara as a smallpox vaccine in people with atopic dermatitis
inferredcites →https://doi.org/10.1016/j.vaccine.2015.06.075openalex-snapshot
Comparison of lyophilized versus liquid modified vaccinia Ankara (MVA) formulations and subcutaneous versus intradermal routes of administration in healthy vaccinia-naïve subjects
inferredcites →https://doi.org/10.1016/s0140-6736(05)17827-1openalex-snapshot
Safety and immunogenicity of new cell-cultured smallpox vaccine compared with calf-lymph derived vaccine: a blind, single-centre, randomised controlled trial
inferredcites →https://doi.org/10.1016/s0140-6736(07)60946-5openalex-snapshot
Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial
inferredcites →https://doi.org/10.1016/s0147-9571(03)00025-0openalex-snapshot
Smallpox vaccination and bioterrorism with pox viruses
inferredcites →https://doi.org/10.1038/nm917openalex-snapshot
Duration of antiviral immunity after smallpox vaccination
inferredcites →https://doi.org/10.1056/nejm196911272812201openalex-snapshot
Complications of Smallpox Vaccination, 1968
inferredcites →https://doi.org/10.1056/nejm198011273032204openalex-snapshot
The Confirmation and Maintenance of Smallpox Eradication
inferredcites →https://doi.org/10.1093/infdis/122.4.303openalex-snapshot
Complications of Smallpox Vaccination, 1968: Results of Ten Statewide Surveys
inferredcites →https://doi.org/10.1093/infdis/161.3.446openalex-snapshot
The Persistence of Neutralizing Antibodies after Revaccination against Smallpox
inferredcites →https://doi.org/10.1093/infdis/jis753openalex-snapshot
Safety, Immunogenicity, and Surrogate Markers of Clinical Efficacy for Modified Vaccinia Ankara as a Smallpox Vaccine in HIV-Infected Subjects
inferredcites →https://doi.org/10.1093/infdis/jit105openalex-snapshot
Safety and Immunogenicity of Modified Vaccinia Ankara in Hematopoietic Stem Cell Transplant Recipients: A Randomized, Controlled Trial
inferredcites →https://doi.org/10.1093/ofid/ofv040openalex-snapshot
Safety and Immunogenicity of Modified Vaccinia Ankara-Bavarian Nordic Smallpox Vaccine in Vaccinia-Naive and Experienced Human Immunodeficiency Virus-Infected Individuals: An Open-Label, Controlled Clinical Phase II Trial
inferredcites →https://doi.org/10.1128/jvi.79.12.7845-7851.2005openalex-snapshot
Modified Vaccinia Virus Ankara Protects Macaques against Respiratory Challenge with Monkeypox Virus
inferredcites →https://doi.org/10.1136/heart.83.5.596openalex-snapshot
Epidemiology, aetiology, and prognosis of heart failure
inferredcites →https://doi.org/10.1159/000156477openalex-snapshot
Can the Immune System Still Be Efficient in the Elderly? An Immunological and Immunoendocrine Therapeutic Perspective
inferredcites →https://doi.org/10.1172/jci33940openalex-snapshot
Survival of lethal poxvirus infection in mice depends on TLR9, and therapeutic vaccination provides protection
inferredcites →https://doi.org/10.1371/journal.pone.0122653openalex-snapshot
Cardiac Safety of Modified Vaccinia Ankara for Vaccination against Smallpox in a Young, Healthy Study Population
inferredcites →https://doi.org/10.1371/journal.pone.0138348openalex-snapshot
A Multicenter, Open-Label, Controlled Phase II Study to Evaluate Safety and Immunogenicity of MVA Smallpox Vaccine (IMVAMUNE) in 18–40 Year Old Subjects with Diagnosed Atopic Dermatitis
inferredcites →https://doi.org/10.1586/14760584.7.8.1225openalex-snapshot
Smallpox vaccines for biodefense: need and feasibility
inferredcites →https://doi.org/10.32607/20758251-2017-9-4-4-12openalex-snapshot
40 Years without Smallpox
inferredcites →https://doi.org/10.3390/v9120378openalex-snapshot
Protection of Mice from Lethal Vaccinia Virus Infection by Vaccinia Virus Protein Subunits with a CpG Adjuvant
inferredcites →https://doi.org/10.4049/jimmunol.171.10.4969openalex-snapshot
Cutting Edge: Long-Term B Cell Memory in Humans after Smallpox Vaccination
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4572849openalex-extracted
Immunogenicity and Reactogenicity of Modified Vaccinia Ankara Pre-Exposure Vaccination Against Mpox According to Previous Smallpox Vaccine Exposure
inferred← citeshttps://doi.org/10.2139/ssrn.4802678openalex-extracted
The Safety, Immunogenicity, and Optimal Dosing of an MVA-Based Vaccine Against MERS Coronavirus in Healthy Adults: A Phase 1b, Randomised, Placebo-Controlled, Double-Blind Clinical Trial
inferred← citeshttps://doi.org/10.1002/rmv.2392openalex-snapshot
Monkeypox: An international epidemic
inferred← citeshttps://doi.org/10.1007/s00203-025-04695-4openalex-snapshot
Monkey pox (Mpox): pathogenesis, genetic shifts, vaccination strategies and clinical insights
inferred← citeshttps://doi.org/10.1007/s11684-022-0952-zopenalex-snapshot
Unusual global outbreak of monkeypox: what should we do?
inferred← citeshttps://doi.org/10.1007/s11904-023-00661-1openalex-snapshot
Mpox and HIV: a Narrative Review
inferred← citeshttps://doi.org/10.1007/s12262-020-02157-3openalex-snapshot
Open Pancreatic Necrosectomy Is Still Safe and Effective Treatment for Pancreatic Necrosis Managed by Step-Up Approach
inferred← citeshttps://doi.org/10.1016/b978-0-12-819727-1.00115-1openalex-snapshot
Environmental Impacts of Tidal and Wave Energy Converters
inferred← citeshttps://doi.org/10.1016/j.biotechadv.2019.107449openalex-snapshot
Nonribosomal peptides in fungal cell factories: from genome mining to optimized heterologous production
inferred← citeshttps://doi.org/10.1016/j.diabres.2019.107813openalex-snapshot
Impaired heart rate variability, Valsalva and 30:15 ratio indexes are associated with reduced submaximal exercise capacity in subjects with diabetes mellitus
inferred← citeshttps://doi.org/10.1016/j.ebiom.2025.105622openalex-snapshot
Development and validation of a quantitative Orthopoxvirus immunoassay to evaluate and differentiate serological responses to Mpox infection and vaccination
inferred← citeshttps://doi.org/10.1016/j.eclinm.2023.102420openalex-snapshot
Immunogenicity and reactogenicity of modified vaccinia Ankara pre-exposure vaccination against mpox according to previous smallpox vaccine exposure and HIV infection: prospective cohort study
inferred← citeshttps://doi.org/10.1016/j.jmb.2023.168173openalex-snapshot
Highly Attenuated Poxvirus-Based Vaccines Against Emerging Viral Diseases
inferred← citeshttps://doi.org/10.1016/j.jpha.2020.01.002openalex-snapshot
Polysaccharide-based chromatographic adsorbents for virus purification and viral clearance
inferred← citeshttps://doi.org/10.1016/j.jsbmb.2021.106037openalex-snapshot
25-hydroxycholesterol–induced cell death via activation of ROCK/LIMK/cofilin axis in colorectal cancer cell spheroids
inferred← citeshttps://doi.org/10.1016/j.medcle.2023.01.005openalex-snapshot
Vaccines against monkeypox
inferred← citeshttps://doi.org/10.1016/j.medcli.2023.01.001openalex-snapshot
Vacunas frente a la viruela del mono (monkeypox)
inferred← citeshttps://doi.org/10.1016/j.supmat.2024.100071openalex-snapshot
WITHDRAWN: Monkeypox: A Timely Update on the Global Outbreak, Transmission, Viral Replication, Vaccination and Clinical Strategies
inferred← citeshttps://doi.org/10.1016/j.vaccine.2017.05.058openalex-snapshot
Comparative Efficacy of Intramuscular and Scarification Routes of Administration of Live Smallpox Vaccine in a Murine Challenge Model
inferred← citeshttps://doi.org/10.1016/j.vaccine.2020.01.055openalex-snapshot
Safety and immunogenicity of novel modified vaccinia Ankara-vectored RSV vaccine: A randomized phase I clinical trial
inferred← citeshttps://doi.org/10.1016/j.vaccine.2020.01.058openalex-snapshot
A randomized phase II trial to compare safety and immunogenicity of the MVA-BN smallpox vaccine at various doses in adults with a history of AIDS
inferred← citeshttps://doi.org/10.1016/j.vaccine.2020.08.050openalex-snapshot
The Brighton Collaboration standardized template for collection of key information for risk/benefit assessment of a Modified Vaccinia Ankara (MVA) vaccine platform
inferred← citeshttps://doi.org/10.1016/j.vaccine.2022.10.078openalex-snapshot
Serological responses to the MVA-based JYNNEOS monkeypox vaccine in a cohort of participants from the Democratic Republic of Congo
inferred← citeshttps://doi.org/10.1016/j.vaccine.2023.12.068openalex-snapshot
Prospective monitoring of adverse events following vaccination with Modified vaccinia Ankara - Bavarian Nordic (MVA-BN) administered to a Canadian population at risk of Mpox: A Canadian Immunization Research Network study
inferred← citeshttps://doi.org/10.1016/j.vaccine.2024.05.017openalex-snapshot
Serologic responses to the MVA-based JYNNEOS mpox vaccine in a cohort of participants from the District of Columbia (D.C.)
inferred← citeshttps://doi.org/10.1016/j.vaccine.2024.126521openalex-snapshot
A Brighton collaboration standardized template with key considerations for a benefit/risk assessment for a viral vector vaccine based on a non-replicating modified vaccinia virus Ankara viral vector
inferred← citeshttps://doi.org/10.1016/s1473-3099(25)00779-0openalex-snapshot
Safety of MVA-BN vaccine in health-care personnel in DR Congo: a prospective cohort study
inferred← citeshttps://doi.org/10.1038/s41392-022-01215-4openalex-snapshot
Monkeypox: epidemiology, pathogenesis, treatment and prevention
inferred← citeshttps://doi.org/10.1038/s41467-020-14495-7openalex-snapshot
Bridging non-overlapping reads illuminates high-order epistasis between distal protein sites in a GPCR
inferred← citeshttps://doi.org/10.1038/s41467-024-48180-wopenalex-snapshot
Predicting vaccine effectiveness for mpox
inferred← citeshttps://doi.org/10.1038/s41467-026-68335-1openalex-snapshot
Sero-genomic evidence for occult mpox exposure in healthy Nigerian adults
inferred← citeshttps://doi.org/10.1039/c9en00461kopenalex-snapshot
Delivery, uptake, fate, and transport of engineered nanoparticles in plants: a critical review and data analysis
inferred← citeshttps://doi.org/10.1056/nejmoa1817307openalex-snapshot
Phase 3 Efficacy Trial of Modified Vaccinia Ankara as a Vaccine against Smallpox
inferred← citeshttps://doi.org/10.1080/21645515.2024.2384189openalex-snapshot
Equivalence of freeze-dried and liquid-frozen formulations of MVA-BN as smallpox and mpox vaccine
inferred← citeshttps://doi.org/10.1089/derm.2022.0013openalex-snapshot
Injection Site Reactions to Monkeypox Vaccine
inferred← citeshttps://doi.org/10.1093/infdis/jiaa490openalex-snapshot
The Impact of Maternal Human Immunodeficiency Virus Infection on the Burden of Respiratory Syncytial Virus Among Pregnant Women and Their Infants, Western Kenya
inferred← citeshttps://doi.org/10.1093/infdis/jiac455openalex-snapshot
One- and Two-Dose Vaccinations With Modified Vaccinia Ankara-Bavarian Nordic Induce Durable B-Cell Memory Responses Comparable to Replicating Smallpox Vaccines
inferred← citeshttps://doi.org/10.1093/infdis/jiae138openalex-snapshot
Mpox-Specific Immune Responses Elicited by Vaccination or Infection in People With HIV
inferred← citeshttps://doi.org/10.1093/milmed/usz181openalex-snapshot
Evidence for Residual Immunity to Smallpox After Vaccination and Implications for Re-emergence
inferred← citeshttps://doi.org/10.1093/ofid/ofaf536openalex-snapshot
Antibody Responses are Sustained 2 Years Post-Mpox Infection but not Following Modified Vaccinia Ankara–Bavarian Nordic Vaccination
inferred← citeshttps://doi.org/10.1097/im9.0000000000000196openalex-snapshot
Mpox as Two Global Health Emergencies: Altered Transmission, Genomics, Clinical Manifestation and Public Health Impact
inferred← citeshttps://doi.org/10.1097/spc.0000000000000257openalex-snapshot
A review of cognitive screening tools in cancer
inferred← citeshttps://doi.org/10.1101/2022.09.07.22279689openalex-snapshot
Single and 2-dose vaccinations with MVA-BN ® induce durable B cell memory responses in healthy volunteers that are comparable to older generation replicating smallpox vaccines
inferred← citeshttps://doi.org/10.1101/2025.06.06.25329130openalex-snapshot
MVA-BN third-dose 5 years after primary; Democratic Republic of the Congo
inferred← citeshttps://doi.org/10.1101/2025.06.11.25328898openalex-snapshot
Safety of MVA-BN in Healthcare Personnel, Democratic Republic of the Congo
inferred← citeshttps://doi.org/10.1101/2025.07.08.25330960openalex-snapshot
Legacy immunity from prior smallpox vaccination and serological evidence of asymptomatic mpox transmission in a West African population
inferred← citeshttps://doi.org/10.1111/1751-7915.13318openalex-snapshot
The art of vector engineering: towards the construction of next‐generation genetic tools
inferred← citeshttps://doi.org/10.1128/msphere.00265-24openalex-snapshot
Recombinant chimeric horsepox virus (TNX-801) is attenuated relative to vaccinia virus strains in both in vitro and in vivo models
inferred← citeshttps://doi.org/10.1136/bmjopen-2026-120064openalex-snapshot
Examining the immune response of participants receiving Modified Vaccinia Ankara vaccine in Africa (MpoxVax AFRIVAC): a prospective cohort study – protocol
inferred← citeshttps://doi.org/10.1177/20499361221136751openalex-snapshot
Poxvirus-driven human diseases and emerging therapeutics
inferred← citeshttps://doi.org/10.1186/s40249-025-01386-6openalex-snapshot
A diagnostic void in the Congo Basin: proposing a zoonotic orthopoxvirus as the cause of a hemorrhagic fever outbreak and a call for equitable health security
inferred← citeshttps://doi.org/10.12659/ajcr.941006openalex-snapshot
The Reemerging Condition of Vaccinia: A Case Report and Brief Review of Monkeypox and Vaccinia Vaccines
inferred← citeshttps://doi.org/10.12788/cutis.0502openalex-snapshot
Acral Papulovesicular Eruption in a Soldier Following Smallpox Vaccination
inferred← citeshttps://doi.org/10.1371/journal.pone.0195897openalex-snapshot
Immunogenicity and safety of three consecutive production lots of the non replicating smallpox vaccine MVA: A randomised, double blind, placebo controlled phase III trial
inferred← citeshttps://doi.org/10.21055/0370-1069-2023-4-24-31openalex-snapshot
Comparison of the Efficacy of Different Schemes for Using Recombinant Vector Vaccines against Ebola Fever, Based on Vaccinia Virus, MVA Strain
inferred← citeshttps://doi.org/10.21055/0370-1069-2025-1-105-111openalex-snapshot
Anti-Vector Immune Response Formed after Immunization with Recombinant Vaccines Based on the Vaccinia Virus, MVA Strain
inferred← citeshttps://doi.org/10.21055/0370-1069-2025-4-6-16openalex-snapshot
Analysis of the Experience of Improving the Safety of Anti-Smallpox Vaccines
inferred← citeshttps://doi.org/10.30895/2221-996x-2023-23-1-26-41openalex-snapshot
Safety and immunogenicity of IMVAMUNE®, a third-generation vaccine based on the modified vaccinia Ankara (MVA) strain
inferred← citeshttps://doi.org/10.32607/20758251-2017-9-4-4-12openalex-snapshot
40 Years without Smallpox
inferred← citeshttps://doi.org/10.3389/fimmu.2023.1182963openalex-snapshot
A recombinant Modified Vaccinia virus Ankara expressing prME of tick-borne encephalitis virus affords mice full protection against TBEV infection
inferred← citeshttps://doi.org/10.3389/fpubh.2022.1021905openalex-snapshot
Current GMP standards for the production of vaccines and antibodies: An overview
inferred← citeshttps://doi.org/10.3390/pathogens11080924openalex-snapshot
Monkeypox and Its Possible Sexual Transmission: Where Are We Now with Its Evidence?
inferred← citeshttps://doi.org/10.3390/v10010021openalex-snapshot
E3L and F1L Gene Functions Modulate the Protective Capacity of Modified Vaccinia Virus Ankara Immunization in Murine Model of Human Smallpox
inferred← citeshttps://doi.org/10.3390/v12020234openalex-snapshot
Field Trial Vaccination against Cowpox in Two Alpaca Herds
inferred← citeshttps://doi.org/10.3390/v15010103openalex-snapshot
Smallpox, Monkeypox and Other Human Orthopoxvirus Infections
inferred← citeshttps://doi.org/10.3390/v16101620openalex-snapshot
Mpox and Lessons Learned in the Light of the Recent Outbreak: A Narrative Review
inferred← citeshttps://doi.org/10.3390/v9090242openalex-snapshot
Are We Prepared in Case of a Possible Smallpox-Like Disease Emergence?
inferred← citeshttps://doi.org/10.3390/v9120378openalex-snapshot
Protection of Mice from Lethal Vaccinia Virus Infection by Vaccinia Virus Protein Subunits with a CpG Adjuvant
inferred← citeshttps://doi.org/10.3390/vaccines10050647openalex-snapshot
Opinion Polls and Antibody Response Dynamics of Vaccination with COVID-19 Booster Vaccines
inferred← citeshttps://doi.org/10.3390/vaccines10091419openalex-snapshot
Preventing the Next Pandemic: Is Live Vaccine Efficacious against Monkeypox, or Is There a Need for Killed Virus and mRNA Vaccines?
inferred← citeshttps://doi.org/10.3390/vaccines10091516openalex-snapshot
Development of Modified Vaccinia Virus Ankara-Based Vaccines: Advantages and Applications
inferred← citeshttps://doi.org/10.3390/vaccines11091410openalex-snapshot
Immunogenicity and Safety of Modified Vaccinia Ankara (MVA) Vaccine—A Systematic Review and Meta-Analysis of Randomized Controlled Trials
inferred← citeshttps://doi.org/10.3390/vaccines12040385openalex-snapshot
A Quadrivalent mRNA Immunization Elicits Potent Immune Responses against Multiple Orthopoxviral Antigens and Neutralization of Monkeypox Virus in Rodent Models
inferred← citeshttps://doi.org/10.3390/vaccines13090930openalex-snapshot
Immune Response to MVA-BN Vaccination for Mpox: Current Evidence and Future Directions
inferred← citeshttps://doi.org/10.36233/0372-9311-102openalex-snapshot
Using the vaccinia virus MVA strain for developing recombinant vector vaccines against current arboviral infections
inferred← citeshttps://doi.org/10.46234/ccdcw2024.025openalex-snapshot
The Current State and Progress of Mpox Vaccine Research
inferred← citeshttps://doi.org/10.52225/narra.v2i3.90openalex-snapshot
Monkeypox: Immune response, vaccination and preventive efforts
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.